Wondfo was honored to be appointed as vice president of Technology Innovation Alliance of the Infectious Disease Diagnostic Reagents Industry.

Wondfo participated in the IFCC-RELA verification for the first time and achieved good outcomes. 11 projects: LDH, ALT, AST, AMY, CK, Glu, Urea, K, Na, Ca, Mg, have all been verified.

Wondfo has completed the application of CE mark for three SARS-CoV-2 antibody rapid tests, making Wondfo the first Chinese medical device company in POCT industry that receives the most CE marks for novel coronavirus antibody test.

Wondfo One Step COVID-19 Antibody Test has successfully approved by National Medical Products Administration.

Two novel coronavirus detection products developed by Guangzhou Wondfo Biotech Co.,Ltd., had the honor to access to emergency approval channel issued by National Medical Products Administration.